S&P 500 slips on report Fed’s Waller leading race to replace Powell; tech shines
NORWELL, Mass. - DIH Holding US, Inc. (NASDAQ:DHAI), a provider of robotic rehabilitation devices with annual revenue of $69.57 million and a gross profit margin of 50.04%, announced Tuesday the appointment of Professor Nick Ward to its Scientific Advisory Board. According to InvestingPro analysis, the company appears undervalued despite recent market challenges.
Ward is a Professor of Clinical Neurology and Neurorehabilitation at University College London’s Institute of Neurology and at the National Hospital for Neurology and Neurosurgery in London. He specializes in upper limb neurorehabilitation and leads a high-intensity rehabilitation program focused on arm and hand function recovery.
The DIH Scientific Advisory Board consists of nine members with expertise across technical and clinical disciplines relevant to rehabilitation solutions. The board advises the company on technical pursuits, clinical trends, product development, and research initiatives.
"Nick’s exceptional clinical expertise in upper limb rehabilitation, his pioneering research and his commitment to high-intensity training make him an invaluable addition," said Dr. Bettina Studer Pastore, Global Head of Scientific and Clinical Affairs at DIH, according to the company’s press release.
Professor Ward stated, "I’m delighted to be joining the DIH Scientific Advisory Board at this exciting time in neurorehabilitation. I hope to bring clinical experience to bear on the future of new approaches to support motor recovery after stroke."
DIH develops robotic devices for physical rehabilitation that incorporate interactive visual stimulation for patients with walking impairments, balance issues, and impaired arm and hand functions. With a current market capitalization of $10.33 million, the company faces near-term challenges, as highlighted by several key metrics available on InvestingPro, including short-term liquidity concerns. However, InvestingPro subscribers have access to over 8 additional exclusive insights about DHAI’s financial health and growth prospects.
In other recent news, DIH Holding US, Inc. has amended an agreement with an investor to address its convertible debenture obligations. The company entered into an Amendment Agreement on May 29, 2025, allowing for the exchange of a portion of its outstanding convertible debenture for common stock shares. This amendment permits future redemption payments and interest payments to be made in either cash or stock. The original agreement, signed in June 2024, involved the sale of $3,300,000 in 8% Senior Secured Convertible Debentures, convertible into Class A common stock at a conversion price of $5.00 per share. However, as of May 1, 2025, there were not enough shares available to cover future conversion payments. Under the new terms, the redemption payment due on May 1, 2025, will be exchanged for 1,540,277 shares of common stock, with future payments to be determined. This transaction aligns with DIH’s financial strategy and has been filed as part of its Current Report. The issuance of these shares complies with the Securities Act, ensuring they cannot be sold in the United States without proper registration or exemption.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.